| PharmaSUG |
2025 |
Roadmap to Efficacy Analysis for Early Phase Oncology studies |
Dhruv Bansal, Christiana Hawn, Chris Kelly |
source |
23 |
| PharmaSUG |
2024 |
A quick guide to SDTM and ADaM mapping of liquid Oncology Endpoints. |
Swaroop Kumar Koduri, Shashikant Kumar, Sathaiah Sanga |
source |
10 |
| PharmaSUG |
2022 |
Above and Beyond Lesion Analysis Dataset (ADTL) |
Raghava Pamulapati |
source |
11 |
| PharmaSUG |
2019 |
Homogenizing Unique and Complex data into Standard SDTM Domains with TAUGs |
Sowmya Srinivasa Mukundan, Charumathy Sreeraman |
source |
10 |
| PHUSE EU |
2018 |
The Oncology-specific Domains TU, TS and RS: What to Know as a Statistical Analyst |
Frieder Wolff, Vitali Gering |
source presentation source |
8 |
| PHUSE US |
2018 |
Split-Coalesce Tumor Data Handling Woes and Safety-Efficacy Dilemma |
Idya Muthukumar |
source presentation source |
11 |
| PharmaSUG |
2017 |
Where Is the Link Broken - Another Look at SDTM Oncology Tumor Packages |
Hong Wang, Ke Xiao |
source |
12 |
| PHUSE EU |
2014 |
Implementation of Oncology Specific SDTM Domains |
Jacintha Eben |
source presentation source |
8 |